Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

Fig. 2

Frequency of best overall response to initial EGFR-TKIs in EGFR mutated NSCLC. a Frequency of best overall response to initial EGFR-TKI treatment among all patients (N = 78). b Frequency of best overall response to initial EGFR-TKI treatment among all patients with the EGFR-T790M mutation (N = 39). c Frequency of best overall response to initial EGFR-TKI treatment across all patients without the EGFR-T790M mutation (N = 39)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us